Balyasny Asset Management’s CVRx CVRX Stock Holding History

Balyasny Asset Management’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-84,500	Closed	-$788K	–	2360
2023 Q1	$788K	Buy	+84,500	New	+$1.12M	﹤0.01%	1825

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management's CVRX Position: Q2 2026 in Review

Balyasny Asset Management sold out of CVRx (CVRX) in Q2 2026, closing a stake of 630,812 shares — an estimated $5.97M sold.

Balyasny Asset Management first reported a position in CVRX in Q2 2021 and held it in 14 quarters. The position peaked at $12.8M in Q4 2023. 87 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

Balyasny Asset Management reported no remaining CVRx position as of Q2 2026 after selling out during the quarter.
Balyasny Asset Management sold 630,812 CVRx shares in Q2 2026, an estimated $5.97M.
Balyasny Asset Management first reported a position in CVRx in Q2 2021 and held it in 14 quarters.
Balyasny Asset Management's CVRx position peaked at $12.8M in Q4 2023.
87 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.